Breast Cancer Clinical Trials in Tampa, FL

Breast Cancer Clinical Trials in Tampa, FL

View the best 10 breast cancer medical studies in Tampa, Florida. Access promising new therapies by applying to a Tampa-based Breast Cancer clinical trial.

Top rated breast cancer clinical trials in Tampa, Florida

Here are the top 10 medical studies for breast cancer in Tampa, Florida

Image of Mayo Clinic Hospital in Arizona in Phoenix, United States.

Olaparib +1 More

PARP Inhibitor

Recruiting1 awardPhase 2
This trial is testing olaparib with or without atezolizumab to treat non-HER2-positive breast cancer that has spread and is not able to be surgically removed or has metastasized.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Trastuzumab Emtansine

Monoclonal Antibodies

Recruiting1 awardPhase 3
This trial tests a combination of two drugs to see if they're better than one drug at preventing breast cancer from coming back in patients with high risk, HER2 positive breast cancer.
Image of The Oncology Institute of Hope & Innovation in Anaheim, United States.

Trastuzumab Deruxtecan (T-DXd) +1 More

Monoclonal Antibodies

Recruiting2 awardsPhase 3
This trial will compare the effectiveness of two drugs for treating breast cancer that has come back after initial treatment.
Image of Highlands Oncology in Springdale, United States.

Fruquintinib +1 More

Tyrosine Kinase Inhibitor

Recruiting1 awardPhase 1 & 2
This trial is testing a new cancer drug, fruquintinib, to see if it is safe and effective when used with tislelizumab to treat patients with locally advanced or metastatic solid tumors. The trial will be conducted in two parts; a Safety Lead-in Phase (Part 1) and a Dose Expansion Phase (Part 2). Part 1 will be open to any-comer solid tumors and will determine the Recommended Phase 2 Dose (RP2D). The RP2D will be administered to four cohorts of patients in Part 2.
Image of Florida Cancer Specialists (St. Petersburg - St. Anthony's Professional Building) in Saint Petersburg, United States.

Inavolisib +2 More

PI3K Inhibitor

Recruiting0 awardsPhase 2 & 3
This trial will study whether adding inavolisib to palbociclib and fulvestrant improves outcomes for women with PIK3CA-mutant, hormone receptor-positive, HER2-negative breast cancer that has progressed after endocrine therapy.
Image of Emad Ibrahim, Md, Inc in Redlands, United States.

Fulvestrant +2 More

Selective Estrogen Receptor Degrader (SERD)

Recruiting2 awardsPhase 3
This trial will compare two cancer treatments to see which is more effective in treating breast cancer that is Advanced or has Metastasized and is estrogen receptor and human epidermal growth factor receptor 2 positive.
Image of Anchorage Associates in Radiation Medicine in Anchorage, United States.

Usual care disease monitoring +1 More

Behavioural Intervention

Recruiting1 award
This trial studies how well using markers to prompt when scans should be ordered works in monitoring patients with hormone receptor positive Her2 negative breast cancer.
Image of ACRC/ Arizona Clinical Research Center in Tucson, United States.

Docetaxel +1 More

Taxane

Recruiting2 awardsPhase 1
This trial looks at whether a different schedule for giving a drug to prevent low white blood cell count works better than the standard schedule.
Image of University of California Los Angeles (UCLA). in Los Angeles, United States.

COM701

Recruiting1 awardPhase 1
This trial is testing a new cancer drug to see if it is safe and effective.
Image of University of South Alabama, Mitchell Cancer Institute ( Site 0020) in Mobile, United States.

Pembrolizumab +2 More

Monoclonal Antibodies

Recruiting1 awardPhase 1
This trial will assess the safety and how the body processes MK-5890 when given alone or with pembrolizumab over the course of 35 administrations. Additionally, the trial will assess the safety of MK-5890 when given with pemetrexed and carboplatin to adults with nonsquamous non-small cell lung cancer or with nab-paclitaxel to adults with triple-negative breast cancer.

Popular filter options for breast-cancer tampa trials

Phase 3 Clinical Trials

View 100 phase 3 medical studies.

Clinical Trials With No Placebo

View 100 medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.